Anticoagulation postablation
Links shared publicly online about this topic.
- 1,370total visits
Anticoagulation postablation
View full resource at theheart.org
Tags: Stroke, Thrombotic Event, Clinical Trial, Anti-Clotting Medication, Anticoagulant, Coumadin
Most Recently Shared on February 19, 2010 at 4:32 pm By:
Warfarin can be stopped at three to six months postablation of AF, but editorial urges caution: Despite the positi... http://bit.ly/azRe7A
Review of the Managing Dabigatran App from ObsHealth for iPhone/iPad
imedicalapps.com — “Review of the Managing Dabigatran App, to Assist Healthcare Providers with the Prescribing and Managing of Pradaxa (Dabigatran)” View full resource at imedicalapps.com
Most Recently Shared on April 17, 2012 at 2:55 pm By:
New app helps clinicians manage new anticoagulant Pradaxa (Dabigatran) http://t.co/OYAv4Pdj
JACC: 10 points to remember on oral anticoagulants in #AFib and ACS
cardiosource.org — “JACC: 10 points to remember on oral anticoagulants in #AFib and ACS” View full resource at cardiosource.org
Most Recently Shared on April 9, 2012 at 11:00 pm By:
JACC: 10 points to remember on oral anticoagulants in #AFib and ACS http://t.co/FAHSo9lF
ACP Internist, April 2012 - New drugs could improve anticoagulation rates
acpinternist.org — “ACP Internist, April 2012 - New drugs could improve anticoagulation rates” View full resource at acpinternist.org
Most Recently Shared on April 5, 2012 at 12:05 pm By:
New drugs could improve anticoagulation rates http://t.co/zred3vVz #ptsafey
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on March 28, 2012 at 2:51 am By:
New oral anticoagulants in #AF: What to do in clinical practice http://t.co/dxgStren
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on March 27, 2012 at 7:56 pm By:
New oral anticoagulants in AF: What to do in clinical practice http://t.co/dRIaE4ER #ACC12
New Designer Drugs for Stroke Prevention in Atrial Fibrillation Patients : Healthymagination
healthymagination.com — “Three new game-changing anticoagulants have been developed for the prevention of strokes in people with atrial fibrillation. The new designer drugs dabigatran, rivaroxaban and apixaban offer significant benefits compared to decades-old warfarin, but there are some downsides to consider.” View full resource at healthymagination.com
Most Recently Shared on March 26, 2012 at 4:45 pm By:
New designer drugs for people suffering with atrial fibrillation: http://t.co/n5MnEwEj
CardioSmart: Your Inside Scoop on the 2012 Convention of the World's Heart Experts
cardiosmart.org — “CardioSmart: Your Inside Scoop on the 2012 Convention of the World's Heart Experts” View full resource at cardiosmart.org
Most Recently Shared on March 26, 2012 at 3:58 pm By:
Get the inside scoop! CardioSmart Patient Correspondant reports from #ACC12. Watch interviews w/ top heart experts http://t.co/kphdSX1i
Novel drug in pill form safer than standard approach to treat blocked lung blood vessels
medicalxpress.com — “A novel oral anti-coagulant outperformed the injected standard therapy on important safety measures for initial and long-term treatment of pulmonary embolism a blockage of lung blood vessels usually caused by a clot and showed comparable efficacy, according to data from the EINSTEIN-PE ...” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 3:30 pm By:
Novel drug in pill form safer than standard approach to treat blocked lung blood vessels http://t.co/tyxObO6R
Infusion of drug into the coronary artery may help reduce size of heart damage after heart attack
medicalxpress.com — “Administration of a bolus dose of the anticoagulant drug abciximab into the coronary artery involved in causing a certain type of heart attack among patients who were undergoing a percutaneous coronary intervention and also receiving another anticoagulant resulted in reduction in the size of damage ...” View full resource at medicalxpress.com
Most Recently Shared on March 25, 2012 at 8:27 pm By:
Infusion of drug into the coronary artery may help reduce size of heart damage after heart attack http://t.co/mUSgd5Lw
Drug Infusion Into Coronary Artery May Help Reduce Size of Heart Damage After Heart Attack
newswise.com — “Administration of a bolus dose of the anticoagulant drug abciximab into the coronary artery involved in causing a certain type of heart attack among patients who were undergoing a PCI and also receiving another anticoagulant resulted in reduction in the size of damage to the heart muscle.” View full resource at newswise.com
Most Recently Shared on March 25, 2012 at 1:49 pm By:
#health news: Drug Infusion Into Coronary Artery May Help Reduce Size of Heart Damage After Heart Attack http://t.co/EFrwVxAr
Drug Infusion Into Coronary Artery May Help Reduce Size of Heart Damage After Heart Attack
newswise.com — “Administration of a bolus dose of the anticoagulant drug abciximab into the coronary artery involved in causing a certain type of heart attack among patients who were undergoing a PCI and also receiving another anticoagulant resulted in reduction in the size of damage to the heart muscle.” View full resource at newswise.com
Most Recently Shared on March 25, 2012 at 1:28 pm By:
Drug Infusion Into Coronary Artery May Help Reduce Size of Heart Damage After Heart Attack http://t.co/n9GdRzYW
Medical News:Debris Prompts Anticoagulant Recall - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “Medical News:Debris Prompts Anticoagulant Recall - in Public Health & Policy, FDA General from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on March 24, 2012 at 7:52 pm By:
Debris Prompts Anticoagulant Recall: (MedPage Today) -- The maker of an argatroban 50 mg/50… http://t.co/GPq2tEPD
Debris Prompts Anticoagulant Recall - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The maker of an argatroban 50 mg/50 mL injection has recalled four lots of the product because of visible particles in the solution.” View full resource at qualitypointtech.net
Most Recently Shared on March 24, 2012 at 6:45 pm By:
Debris Prompts Anticoagulant Recall: (MedPage Today) -- The maker of an argatroban 50 mg/50 mL injection has recal... http://t.co/qUYeyR52
Medical News:Debris Prompts Anticoagulant Recall - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “Medical News:Debris Prompts Anticoagulant Recall - in Public Health & Policy, FDA General from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on March 24, 2012 at 6:36 pm By:
Medical News:Afib, Stroke, and the New Anticoagulants, a Roundtable - in Cardiovascular, Strokes from MedPage Today
medpagetoday.com — “Medical News:Afib, Stroke, and the New Anticoagulants, a Roundtable - in Cardiovascular, Strokes from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on March 22, 2012 at 10:40 pm By:
#Afib, #Stroke, and the New #Anticoagulants, a Roundtable http://t.co/bv84wUu2
Advertisement

